Patients With Chronic Obstructive Pulmonary Disease

COPD is one of the many preventable diseases that health care providers deal with. Nurses needs to familiarize themselves with this disease process and how it affects the body, preventative methods, and treatment plans, so that they can be well informed when it comes to patient education. Education is a big part of nursing and considering COPD is the third leading cause of death, nurses will be in frequent contact with

I work as a respiratory therapist and treat patients diagnosed with chronic obstructive pulmonary disease (COPD). Smoking is a leading cause associated with developing COPD. As a professional working in the healthcare field, I have been fortunate and educated about the dangers and consequences linked to cigarette smoking. I have treated and have experience with individuals who have smoked and developed COPD. Also, as an educator, I have tried to help individuals quit smoking to improve overall health. As an educator, I view smoking as an addiction to the drug nicotine and managing cravings will help individuals quit smoking.

Chronic Obstructive Pulmonary Disease (COPD) is progressively common amongst patients within the United States. The disease is more common in patients with a long smoking history. Inflammatory changes are largely responsible for the development and symptoms of COPD. COPD is typically managed according to classification of severity based on the GOLD guidelines. Anoro Ellipta is a new once daily FDA approved drug. It is a combination of a long-acting muscarinic antagonist (LAMA) and a long-acting b2-agonist that should be considered in the management of COPD. Efficacy studies have proved Anoro Eliipta in preventing COPD exacerbations and show it is well tolerated amongst patients.

Eve Ensler said “I wake up every day and I think, 'I 'm breathing! It 's a good day.” Breathing is extremely important activity it allows us to take in and release vital elements to keep us alive, but there are diseases that can hinder us from breathing properly. A disease on the rise and one of the top three leading causes of death in America is Chronic Obstructive Pulmonary Disease (COPD) it is the third leading cause of death in America, claiming the lives of 134,676 Americans in 2010 alone. In 2011, an estimated 10.1 million Americans reported a physician diagnosis of chronic bronchitis. (COPD Statistics across America, 2015). COPD is a very serious disease that is claiming the lives of people every day. COPD is a preventable disease, only if people were better informed and educated on COPD there would be less cases and less deaths of the disease. How can we put an end to the suffering and deaths of those that contract the disease? The first thing that people can do is educate ourselves and other about the disease so the awareness will be on the minds of the people that may make the right choice to avoid certain pitfalls to contract the disease.

Chronic Obstructive Pulmonary Disease (COPD) is currently defined as a progressive, but preventable and treatable disease that affects a person’s ability to breath. According to a recent statistical report done by Ford et al. (2013), the prevalence rate for COPD in the United States in 2011 was 13.7 million adults (Ford et al., 2013). The report stated that the majority of individuals diagnosed with COPD are over 45 years of age, with the highest number of individuals being 55-64 years of age. Furthermore, the authors found that women are more often diagnosed than men. In terms of prevalence based on race, the report indicated that non-Hispanic white individuals are more likely to be diagnosed with COPD than non-Hispanic African Americans or

Chronic obstructive pulmonary disease (COPD) is a lung disorder characterized by a small airway obstruction and reduction in expiratory flow rate (Arcangelo & Peterson, 2013). It affects over ten percent of the United States’ population, is the 4th leading cause of death, and costs over $37 billion annually to treat (Arcangelo & Peterson, 2013). In 2013, 2.8% of every 100,000 diagnosed with COPD, died from chronic bronchitis or emphysema related causes (CDC, 2014). Common risk factors for the development of COPD include smoking, air pollution, chronic respiratory infections, and hyperresponsive airways due to asthma (Arcangelo & Peterson, 2013). Unfortunately, early signs and symptoms of COPD are practically nonexistent. Once a patient starts exhibiting symptoms, the disease has progressed significantly (Arcangelo & Peterson, 2013). Pulmonary function tests are essential to diagnose COPD. Forced vital capacity, or the maximum amount of air exhaled with force, indicates lung size (Arcangelo & Peterson, 2013). Forced expiratory volume (FEV1) measures the maximum amount of air expired in one second (Arcangelo & Peterson, 2013). FEV1 and symptoms exhibited are used to stage COPD (Arcangelo & Peterson, 2013). COPD is staged at five levels of severity (Refer to Appendix for severity scale). The severity of COPD is defined by FEV 1 %, or the maximal amount of air forcefully exhaled in one second using spirometry (Timmins, et.al., 2012). Emphysema and chronic

Chronic Obstructive Pulmonary Disease (COPD) is one of the leading cause of death in the world. Because smoking is the main cause of COPD, abstinence from smoking manages it. Medical researchers have conducted novel research to observe the effectiveness of smoking cessation on COPD patients, while some have summarized and analyzed previous research to recommend involvement of nurses in intervention programs. The main aim of research in this field is to measure the severity of the disease and analyze the possible effective ways of reducing the harsh effects of smoking in COPD patients. Research in this field also draws scholarships from broad topics like use of ATS guidelines to measure the severity of restrictive lung disease. The research

Chronic Obstructive pulmonary disease (COPD) has been known as umbrella diagnosis of multiple pulmonary disorders. COPD is a complex disorder that is very prevalent in the older adult population and causes significant complications in the older adult due to age related aspects and multiple co morbidities that are involved. According to the World Health Organization, COPD is defined as chronic obstruction of lung airflow that can be irreversible and results in decreased pulmonary lung function. COPD consists of two intertwined which are difficult to distinguish which are chronic bronchitis and emphysema. Chronic bronchitis is an inflammation of the lining of your bronchial tubes, and emphysema occurs when the alveoli are gradually destroyed. The American College of Chest Physicians defines chronic bronchitis as "productive cough that is present for a period of 3 months in each of 2 consecutive years in the absence of another identifiable cause of excessive sputum production". COPD can be difficult to manage in the older adult due to several factors such as frailty, cognitive decline, co morbid conditions, medication adherence, and lack of support and understanding of the disease. These factors can result in readmissions to hospitals, poor patient outcomes and increase in morbidity and mortality.

The following report is a case study of an 86 year old male suffering respiratory distress as a result of chronic obstructive pulmonary disease (COPD).

Chronic obstructive pulmonary disease (COPD) is one of the most common types of lung disease that includes emphysema and chronic bronchitis. This abnormal lung inflammatory response is characterized by a persistent airflow obstruction, which is not fully reversible (Lee, Kim, & Tagmazyan, 2013). COPD is a major public health problem as it causes major disability, morbidity, and mortality. Moreover, economic consequences of COPD are substantial. In 2010, the estimated total societal cost of COPD attribution in the United State was $ 36 billion (Center for Disease Prevention and Control [CDC], 2015).

Based on the information provided; the three differential diagnosis that are being considered include; chronic obstructive pulmonary disease (COPD), bronchitis and community acquired pneumonia (CAP) (Papadakis, McPhee, & Rabow, 2015).

Chronic obstructive pulmonary disease (COPD) is a chronic lung disease that makes it difficult to breathe. People often show symptoms of this disease during later stages and rarely in the early phase. Generally smoking and inhaling polluted air is the cause of COPD. It’s critical to detect the symptoms early in order to treat more effectively. Doctor will test for this disease by conducting a physical exam and perform laboratory tests. Spirometry is a test that uses to indicate the status of your lung’s expansion and contraction. You blow air into a tubing that attached to a machine, and it measures the amount of air you blow out and the rate that this is happening.

Over the years Chronic Obstructive Pulmonary Disease (COPD) has been a vastly under-identified and under-treated, causing the World Health Organization (WHO) to undertake increased worldwide awareness concerning the disease. Thus the Global Initiative for Chronic Obstructive Lung Disease (GOLD) was created in order to educate the world and set standardized practices.1,2 COPD is defined by the chronic obstruction of the airway relating to inflammatory diseases of the bronchial tubes. The restrictive airflow, while preventable and treatable, is often fast progressing and not completely reversible1. COPD includes diseases such as chronic bronchitis, emphysema, and small airway disease as all these conditions include a chronic narrowing of

Chronic Obstructive Pulmonary disorder (COPD) is a very prevalent disease in the world today with the most common cause being related to tobacco smoke. Not only is it associated with lung disease, but it has also been seen to be linked with many other comorbidities. However, the most concerning effect that COPD has on the body is towards the muscular dysfunction of skeletal muscle. Reasons, that are independent of lung function, that make this so concerning includes; an overall decrease in functional capacity, a poor quality of life, an increase in health care utilization, or even mortality. COPD has been linked to vitamin D deficiency. However, the effects of Vitamin D deficiency, pertaining to COPD, on skeletal muscle has

Chronic obstructive pulmonary disease (COPD) is a multisystemic disease that often coexists with comorbidities that may have significant impact on prognosis.1-8 Some of these comorbidities arise independently of COPD whereas others may be causally related, either with shared risk factors or by one disease increasing the risk or compounding the severity of the other.9 Although many risk factors contribute to the development of COPD, cigarette smoking is still considered the most well studied COPD risk factor.10 Several studies reported the significant effect of smoking on hearing loss.11,12 In a previous research, the impact of chronic hypoxaemia secondary to COPD on the auditory function of these patients was investigated. Results showed a statistically significant difference for all auditory measures between patients with COPD